期刊文献+

定量感觉检查在糖尿病周围神经病变早期筛查中的灵敏度和特异度研究 被引量:2

The sensitivity and specificity of quantitative sensory testing in screening diabetic peripheralneuropathy of the early stage
原文传递
导出
摘要 目的 探讨定量感觉检查(QST)在糖尿病周围神经病变早期筛查中的临床意义.方法 分别对100例2型糖尿病患者进行神经传导速度检查和QST,以神经传导速度检查结果阳性为诊断糖尿病周围神经病变的金标准,探讨QST用于早期筛查糖尿病周围神经病变的灵敏度和特异度.结果 100例2型糖尿病患者中.神经传导速度检查结果阳性者41例,阴性者59例;同时QST阳性者74例,阴性者26例.QST用于早期筛查糖尿病周围神经病变的灵敏度为97.56%(40/41),特异度为42.37%(25/59).结论 QST在糖尿病周围神经病变的早期筛查中灵敏度较高,但特异度较低,可作为常规肌电图的补充检查. Objective To evaluate the clinical significance of quantitative sensory testing (QST) in screening diabetic peripheral neuropathy of the early stage. Methods One hundred patients with type 2 diabetes mellitus were examined by nerve conduction velocity (NCV) and QST examination. With the NCV positive as the gold criterion for screening diabetic peripheral neuropathy of the early stage, the sensitivity and specificity of QST was further analyzed for diagnosis of the early stage diabetic peripheral neuropathy. Results Among the 100 patients with type 2 diabetes mellitus,there were 41 cases positive and 59 cases negative in NCV examination. On the other hand,there were 74 cases positive,and 26 cases negative in QST. The sensitivity and specificity of QST for the diagnosis of early stage diabetic peripheral neuropathy was 97.56% (40/41) and 42.37% (25/59). Conclusions In the screening of early stage diabetic peripheral neuropathy,QST shows higher detection sensitivity,but lower specificity than NCV examination. Therefore, QST may be an examination for the supplement of the routine electromyography.
出处 《中国医师进修杂志》 2011年第13期27-30,共4页 Chinese Journal of Postgraduates of Medicine
关键词 糖尿病神经病变 敏感性与特异性 肌电图描记术 定量感觉检查 Diabetic neuropathies Sensitivity and specificity Electromyography Quantitativesensory testing
  • 相关文献

参考文献10

  • 1Kles KA,Vinik AI.Pathophysiology and treatment of diabetic peripheral neuropathy:the case for diabetic neurovascular function as an essential component.Curr Diabetes Rev,2006,2(2):131-145.
  • 2张昆林,毛小川,刘江,马莎,丁里.糖尿病早期周围神经病变患者神经传导速度及定量感觉检查检测分析[J].中国医师进修杂志(内科版),2009,32(11):18-20. 被引量:8
  • 3Chong MS,Hester J.Diabetic painful neuropathy:current and future treatment options.Drugs,2007,67(4):569-585.
  • 4Rauck RL,Shaibani A.Boiton V,et al.Lacosamide in painful diabetic peripheral neuropathy:a phase 2 double-blind placebocontrolled study.Clin J Pain,2007,23(2):150-158.
  • 5Sugimoto K,Yasujima M,Yagihashi S.Role of advanced glycation end products in diabetic neuropathy.Curr Pharm Des,2008,14 (10):935-961.
  • 6Chattopadhyay M,Mata M,Fink DJ.Continuous deha-opioid receptor activation reduces neurons] voltage-gated sodium channel (NaV1.7) levels through activation of protein kinase C in painful diabetic neuropathy.J Neurosci,2008,28(6):6652-6658.
  • 7Ruessmann HI.Switching from pathogenetic treatment with alphalipoic acid to gabapentin and other analgesics in painful diabetic neuropathy:a real-world study in outpatients.J Diabetes Complications,2009,23(3):174-177.
  • 8Viola V,Newnham HH,Simpson RW.Treatment of intractable painful diabetic neuropathy with intravenous lignocaine.J Diabetes Complications,2006,20(1):34-39.
  • 9Boulton AJ,Malik RA.Arezzo JC.et al.Diabetic somatic neuropathies.Diabeters Care,2004,27(6):1458-1486.
  • 10Siemionow M,Alghoul M,Molski M,et al.Clinical outcome of peripheral nerve decompression in diabetic and nondiabetic peripheral neuropathy.Ann Plast Surg,2006,57(4):385-390.

共引文献7

同被引文献9

引证文献2

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部